Eli Lilly's experience of complying with strict Turkish serialisation requirements has taught them how to handle future implementation of serialisation globally in a more effective manner, explains Hicham Safine, Europe/AMEA/CIS Quality Consultant at Eli Lilly. And just how will the Falsified Medicine Directive impact the pharmaceutical industry when fully implemented?
You may be interested in: Maximising Packaging and Labelling to ensure Patient Compliance
|
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |